- Home
- ARQQ vs CCEL Comparison
ARQQ vs CCEL Comparison
Compare ARQQ & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- CCEL
- Stock Information
- Founded
- ARQQ 2017
- CCEL 1989
- Country
- ARQQ United Kingdom
- CCEL United States
- Employees
- ARQQ N/A
- CCEL N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- CCEL Managed Health Care
- Sector
- ARQQ Technology
- CCEL Health Care
- Exchange
- ARQQ Nasdaq
- CCEL Nasdaq
- Market Cap
- ARQQ 173.1M
- CCEL 56.8M
- IPO Year
- ARQQ N/A
- CCEL 1997
- Fundamental
- Price
- ARQQ $13.39
- CCEL $6.40
- Analyst Decision
- ARQQ Strong Buy
- CCEL Strong Buy
- Analyst Count
- ARQQ 1
- CCEL 1
- Target Price
- ARQQ $52.00
- CCEL $8.50
- AVG Volume (30 Days)
- ARQQ 300.7K
- CCEL 15.7K
- Earning Date
- ARQQ 12-05-2024
- CCEL 04-14-2025
- Dividend Yield
- ARQQ N/A
- CCEL 3.91%
- EPS Growth
- ARQQ N/A
- CCEL N/A
- EPS
- ARQQ N/A
- CCEL 0.05
- Revenue
- ARQQ $293,000.00
- CCEL $31,986,106.00
- Revenue This Year
- ARQQ $1,818.77
- CCEL $2.21
- Revenue Next Year
- ARQQ N/A
- CCEL $0.98
- P/E Ratio
- ARQQ N/A
- CCEL $129.21
- Revenue Growth
- ARQQ N/A
- CCEL 2.05
- 52 Week Low
- ARQQ $3.72
- CCEL $5.35
- 52 Week High
- ARQQ $52.79
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- ARQQ 41.14
- CCEL 38.03
- Support Level
- ARQQ $11.06
- CCEL $6.39
- Resistance Level
- ARQQ $13.30
- CCEL $7.70
- Average True Range (ATR)
- ARQQ 1.36
- CCEL 0.61
- MACD
- ARQQ 0.28
- CCEL -0.11
- Stochastic Oscillator
- ARQQ 35.11
- CCEL 10.64
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.